All posts tagged
Galapagos and Gilead Launch the Fifth New Trial for Filgotinib this Year
With Actelion’s Acquisition Done, What are the Largest European Biotechs?
BRIEF: Galapagos and Gilead add Lupus to their Growing List of Indications
Galapagos Shoots Past its IPO in a New Public Round of €315M
Galapagos Launches 3 New Trials to Expand into Profitable Indications
Galapagos Enters Clinical Trials with New Cystic Fibrosis Drug
What are the Best Countries to Recruit Biotech Talents in 2017?
Galapagos finds a Partner to Boost its Pipeline with Drug Combinations
Infographic: The Biggest Biotech Company in Each European Country
Galapagos kicks off a Phase IIa trial for Cystic Fibrosis
Galapagos gets another Milestone Payment from Gilead
One Step Closer to the First Triple Combination Therapy for Cystic Fibrosis
Labiotech UG, All Rights Reserved -
Send this to friend